A comparative study on several models of experimental renal calcium oxalate stones formation in rats

Abstract

In order to compare the effects of several experimental renal calcium oxalate stones formation models in rats and to find a simple and convenient model with significant effect of calcium oxalate crystals deposition in the kidney, several rat models of renal calcium oxalate stones formation were induced by some crystal-inducing drugs (CID) including ethylene glycol (EG), ammonium chloride (AC), vitamin D₃[1α(OH)VitD₃, alfacalcidol], calcium gluconate, ammonium oxalate, gentamicin sulfate, L-hydroxyproline. The rats were fed with drugs given singly or unitedly. At the end of experiment, 24-h urines were collected and the serum creatinine (Cr), blood urea nitrogen (BUN), the extents of calcium oxalate crystal deposition in the renal tissue, urinary calcium and oxalate excretion were measured. The serum Cr levels in the stone-forming groups were significantly higher than those in the control group except for the group EG+L-hydroxyproline, group calcium gluconate and group oxalate. Blood BUN concentration was significantly higher in rats fed with CID than that in control group except for group EG+L-hydroxyproline and group ammonium oxalate plus calcium gluconate. In the group of rats administered with EG plus Vitamin D₃, the deposition of calcium oxalate crystal in the renal tissue and urinary calcium excretion were significantly greater than other model groups. The effect of the model induced by EG plus AC was similar to that in the group induced by EG plus Vitamin D₃. EG plus Vitamin D₃ or EG plus AC could stably and significantly induced the rat model of renal calcium oxalate stones formation.

Keywords

calcium oxalate / rat model / crystal-inducing drug

References

[1] de WaterR., BoeveE. R., van MiertP. P., et al.. Pathological and immunocytochemical changes in chronic calcium oxalate nephrolithiasis in the rat. Scanning Micros, 1996, 10: 577-590

[2] KumarS., SigmonD., MillerT., et al.. A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol, 1991, 146: 1384-1389

[3] de WaterR., BoeveE. R., van MiertP. P., et al.. Experimental neprholithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. Scanning Microsc, 1996, 10: 591-601

[4] GregoryJ. G., ParkK. Y., BuinsT., et al.. RyailR., BrockisJ. G., MarshallV., et al.. The interaction of urinary oxalate calcium and pH in renal calculi formation as a demonstration in a rat model. Urinary Stone, 1984, New York, Livingston: 355

[5] PizzllatoP.. Mercurous nitrate as a histochemical reagent for calcium phosphate in bone and pathological calcification and for calcium oxalate. Histochem J, 1971, 3: 463-469

[6] YachikuS., KamidateT.. The determination of urinary oxalate by gas-chromatography. Nippon Hinyokika Gakkai Zasshi, 1985, 76: 502-507

[7] de BruijnW. C., BoeveE. R., van RunP. R., et al.. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?. Scanning Microsc, 1995, 9: 103-115

[8] KhanS. R., ShevockP. N., HackettR. L.. Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol, 1992, 147: 226-230

[9] CaoL. C., BoeveE. R., de BruijnW. C., et al.. A review of new concepts in renal stone research. Scanning Microsc, 1993, 7: 1049-1064

[10] BalajiK. C., MenonM.. Mechanism of stone formation. Urol Clin North Am, 1997, 24: 1-11

[11] de WaterR., NoordermeerC., van der KwastT. H., et al.. Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitum. Am J Kidney Dis, 1999, 33: 761-771

[12] GokhaleJ. A., GlentonP. A., KhanS. R.. Localization of tamm-horsfall protein and osteopontin in a rat nephrolithiasis model. Nephron, 1996, 73: 456-461

[13] MiyakeO., YoshiokaT., YoshimuraK., et al.. Expression of Tamm-Horsfall protein in stone-forming rat models. Br J Urol, 1998, 81: 14-19

[14] ChahwalaS. B., HarpurE. S.. Gentamicin-induced hypercalciuria in the rat. Acta Pharmacol. Toxicol, 1983, 53: 358-362

[15] BuckA. C., DaviesR. L., HarrisonT.. The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis. J Urol, 1991, 146: 188-194